COVID-19 disease and immune dysregulation

被引：36
|
作者：
Davitt, Ethan [1 ]
Davitt, Colin [2 ]
Mazer, Monty B. [3 ,5 ]
Areti, Sathya S. [4 ]
Hotchkiss, Richard S. [1 ,2 ]
Remy, Kenneth E. [2 ,3 ,4 ,5 ,6 ]
机构：
[1] Washington Univ, Sch Med, St Louis, MO USA
[2] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO USA
[3] Univ Hosp Cleveland, Dept Pediat, Cleveland, OH USA
[4] Univ Hosp Cleveland, Dept Internal Med, Cleveland, OH USA
[5] Case Western Reserve Univ, Sch Med, Cleveland, OH USA
[6] Case Western Reserve Univ, Univ Hosp Cleveland, Sch Med, Dept Internal Med, 11100 Euclid Ave, Cleveland, OH 44106 USA
来源：
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY | 2022年 / 35卷 / 03期
基金：
美国国家卫生研究院;
关键词：
COVID-19; SARS-CoV-2; Immunology; Host immune response; Innate; Adaptive; COMPLEMENT ACTIVATION; INFECTION;
D O I：
10.1016/j.beha.2022.101401
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The SARS-CoV-2 virus has complex and divergent immune alterations in differing hosts and over disease evolution. Much of the nuanced COVID-19 disease immune dysregulation was originally dominated by innate cytokine changes, which has since been replaced with a more complex picture of innate and adaptive changes characterized by simultaneous hyperinflammatory and immunosuppressive phenomena in effector cells. These intricacies are summarized in this review as well as potential relevance from acute infection to a multisystem inflammatory syndrome commonly seen in children. Additional consideration is made for the influence of variant to variant host cellular changes and the impact of potential vaccination upon these phenotypes. Finally, therapeutic benefit for immune alterations are discussed.
引用
收藏
页数：8
相关论文
共 50 条
  • [41] Immune biomarkers associated with COVID-19 disease severity in an urban, hospitalized population
    Chambliss, Allison B.
    Aljehani, Mayada
    Tran, Brian
    Chen, Xingyao
    Elton, Elizabeth
    Garri, Carolina
    Ung, Nolan
    Matasci, Naim
    Gross, Mitchell E.
    PRACTICAL LABORATORY MEDICINE, 2023, 36
  • [42] T-cell dysregulation in COVID-19
    Kalfaoglu, Bahire
    Almeida-Santos, Jose
    Tye, Chanidapa Adele
    Satou, Yorifumi
    Ono, Masahiro
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 538 : 204 - 210
  • [43] Dysregulation of Pulmonary Responses in Severe COVID-19
    Wu, Dandan
    Yang, Xuexian O.
    VIRUSES-BASEL, 2021, 13 (06):
  • [44] Myeloid dysregulation and therapeutic intervention in COVID-19
    Gu, Runxia
    Mao, Tianyang
    Lu, Qiao
    Su, Tina Tianjiao
    Wang, Jun
    SEMINARS IN IMMUNOLOGY, 2021, 55
  • [45] Effects of COVID-19 Disease on DNA Damage, Oxidative Stress and Immune Responses
    Basaran, M. Mert
    Hazar, Merve
    Aydin, Mehtap
    Uzug, Gulsum
    Ozdogan, Ilkima
    Pala, Emin
    Dilsiz, Sevtap Aydin
    Basaran, Nursen
    TOXICS, 2023, 11 (04)
  • [46] Differential gene expression of immune response in COVID-19 and its relationship with progression of COVID-19
    Li, Yun-Xi
    Wen, Yang-Cheng
    Li, Zhen-Yue
    Ou, Pei-Yu
    HUMAN IMMUNOLOGY, 2024, 85 (06)
  • [47] Monitoring the COVID-19 immune landscape in Japan
    Sasanami, Misaki
    Kayano, Taishi
    Nishiura, Hiroshi
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 122 : 300 - 306
  • [48] Immune response to COVID-19 in older adults
    Jergovic, Mladen
    Coplen, Christopher P.
    Uhrlaub, Jennifer L.
    Nikolich-Zugich, Janko
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (10) : 1082 - 1089
  • [49] Dynamics of the intensity of the immune response in COVID-19
    Makarova, Ekaterina
    Lyubavina, Natalya
    Milyutina, Marina
    Polyakova, Irina
    Nekaeva, Ekaterina
    Galova, Elena
    Odintsov, Gennady
    Menkov, Nikolay
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [50] Association of KIR gene polymorphisms with COVID-19 disease
    Hajeer, Ali
    Jawdat, Dunia
    Massadeh, Salam
    Aljawini, Nora
    Abedalthagafi, Malak S.
    Arabi, Yaseen M.
    Alaamery, Manal
    CLINICAL IMMUNOLOGY, 2022, 234
12345